Of particular importance for the herein work, the implication of Fra-1 in tumor aggressiveness has been particularly well studied in triple-negative breast cancers (TNBC), which account for 15% of all breast cancers (BC) and are the most-deadly BC subtype. The gene discussed is FOSL1; the disease is breast cancer.